Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem

  title={Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem},
  author={Takashi Kato and Hiroshi Fukatsu and Kengo Ito and Masanori Tadokoro and Toyohiro Ota and Mitsuru Ikeda and Takayuki Isomura and Shigeki Ito and Masanari Nishino and Takeo Ishigaki},
  journal={European Journal of Nuclear Medicine},
The aim of this study was to examine the significance and problems of 2-[fluorine-18]-2-deoxy-d-glucose (FDG) positron emission tomography (PET) in diagnosing pancreatic cancer and mass-forming pancreatitis (MFP). PET, X-ray computed tomography (CT) and magnetic resonance (MR) imaging were performed in 15 patients with pancreatic cancer and nine patients with MFP. The areas of the PET scan were determined according to the markers drawn on the patients at CT or MR imaging. Regions of interests… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 12 extracted citations


Publications referenced by this paper.
Showing 1-10 of 26 references

Diagnostic usefulness and limitation of FDG-PET in recurrent rectal cancer

  • K Ito, T Kato, M Ohta, M Tadokoro, T Ishiguchi, T. Ishigaki
  • Matsuazwa T, ed. Proceeding of the second…
  • 1994
Highly Influential
3 Excerpts

Pancreatic adenocarcinoma: radiographic diagnosis and staging

  • DH Stephens
  • Freeny PC, Stevenson GW, eds. Alimentary tract…
  • 1994
1 Excerpt

Concordantly increased glucose transporter 1 (GLUT 1) gene expression and FDG-uptake in human pancreatic carcinoma

  • D Kornrumpf, M Bachler, J Langhans, HG Beger, SN. Reske
  • J Nucl Med
  • 1993
1 Excerpt

creatic cancer detected by positron emission tomography with ~ SF - labelled deoxyglucose : method and first results

  • R Bares, D KleverRHellwig, +5 authors V Schumpelick
  • Nucl Med Commun
  • 1993

Similar Papers

Loading similar papers…